Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
82 hedge funds and large institutions have $61.1M invested in Enzo Biochem, Inc. in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 11 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
5% less capital invested
Capital invested by funds: $64.1M → $61.1M (-$2.99M)
2% less funds holding
Funds holding: 84 → 82 (-2)
11% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 27
12% less call options, than puts
Call options by funds: $149K | Put options by funds: $169K
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
+$4.14M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$408K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$388K |
| 4 |
Renaissance Technologies
New York
|
+$289K |
| 5 |
Squarepoint
New York
|
+$279K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.4M |
| 2 |
EGA
Evermore Global Advisors
Summit,
New Jersey
|
-$633K |
| 3 |
Russell Investments Group
London,
United Kingdom
|
-$566K |
| 4 |
Charles Schwab
San Francisco,
California
|
-$375K |
| 5 |
Millennium Management
New York
|
-$354K |
ENZ Hedge Fund Activity: Q3 2020 in Review
82 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q3 2020, worth a combined $61.1M — down 4.7% from $64.1M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of ENZ and 9 opened new positions — a net loss of 2 holders — while 27 trimmed existing stakes and 24 added.
The largest buyer was Roumell Asset Management, adding an estimated $4.14M. The largest seller was Wellington Management Group, exiting entirely with an estimated $2.4M sold.
- 82 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q3 2020, down from 84 in Q2 2020.
- Funds reported $61.1M of Enzo Biochem, Inc. stock for Q3 2020, down 4.7% quarter-over-quarter.
- 9 funds opened new Enzo Biochem, Inc. positions in Q3 2020 and 11 closed out, a net change of -2 holders.
- The largest Enzo Biochem, Inc. buyer in Q3 2020 was Roumell Asset Management, an estimated $4.14M added.
- The largest Enzo Biochem, Inc. seller in Q3 2020 was Wellington Management Group, an estimated $2.4M sold.
Based on aggregated 13F filings for Q3 2020.